REAGENT or RESOURCE | SOURCE | IDENTIFIER |
---|---|---|
Antibodies | ||
Anti- Gasdermin D (N-terminal), 1: 1000 | ab215203;RRID: AB_2916166 | Abcam |
Anti- Gasdermin D (C-terminal), 1: 1000 | ab210070;RRID: AB_2893325 | Abcam |
Anti- NLRP1 (N-terminal), 1: 1000 | AF6788-SP;RRID: AB_2916167 | R&D system |
Anti- NLRP1 (C-terminal), 1: 1000 | ab36852;RRID: AB_776633 | Abcam |
Anti -ACE2, 1: 1000 | ab108252;RRID: AB_10864415 | Abcam |
Anti -TMPRSS2, 1: 1000 | ab92323;RRID: AB_10585592 | Abcam |
Anti-actin 1: 5000 | A1978;RRID: AB_476692 | Sigma-Aldrich |
anti-Sheep igG HRP (1/4000) | HAF016;RRID: AB_562591 | R&D |
Goat anti-mouse HRP (1/4000) | 1034-05;RRID: AB_2794340 | SouthernBiotech |
Goat-anti-rabbit IgG (H+L), HRP conjugate (1/4000) | R-05072-500;RRID: AB_10719218 | Advansta |
Rabbit anti-Goat IgG (H+L) Secondary Antibody, HRP (1/4000) | 81-1620;RRID: AB_2534006 | Invitrogen |
Donkey anti-Rabbit IgG (H&L) - Affinity Pure, DyLight®550 Conjugate (1/1000 IF) | DkxRb-003-D550NHSX;RRID: AB_2916168 | ImmunoReagents |
Anti Caspase 8 (1: 1000) | ALX-804-242-C100;RRID: AB_2050949 | Enzo Life |
Anti Caspase 1 (1: 1000) | AG-20B-0048-C100;RRID: AB_2916169 | Adipogen |
Anti Caspase 3 (1: 1000) | 9662S;RRID: AB_331439 | Cell Signaling |
Anti gasdermin E (1: 1000) | Ab215191;RRID: AB_2737000 | Abcam |
Anti SARS NSP5 (1: 1000) | NBP3-07061;RRID: AB_2916170 | Novusbio |
Anti SARS Nucleocapsid (1: 1000) | NB100 56683;RRID: AB_838841 | Novusbio |
Bacterial and virus strains | ||
BetaCoV/France/IDF0372/2020 | Sylvie van der Werf and the National Reference Centre for Respiratory Viruses | Institut Pasteur (Paris, France) |
hCoV-19/USA/MD-HP05647/2021 (Delta Variant) | BEI | |
hCoV-19/USA/OR-OHSU-PHL00037/2021 (Alpha Variant) | BEI | |
hCoV-19/Japan/TY7-503/2021 (Gamma Variant) | BEI | |
Biological samples | ||
Plasma from Covid patients | Covid Biotoul cohort/Toulouse, France | Hospital of Toulouse |
Plasma from patients with inborn mutations or autoantibodies | Institut Imagine/Covid genetic effort | Institut Imagine, Paris/France |
Chemicals, peptides, and recombinant proteins | ||
Z-VAD: 40 μM | tlrl-vad | Invivogen |
Y-VAD: 40 μM | inh-yvad | Invivogen |
Z-DEVD: 40 μM | S7312 | Selleck Chemicals |
Z-IETD: 40 μM | inh-ietd | Invivogen |
MCC950: 10 μM | inh-mcc | Invivogen |
VX765: 10 μM | inh-vx765i-1 | Invivogen |
DMF: 10 μM | S2586 | Selleck Chemicals |
MLN4924: 1 μM | 6499 | Tocris |
Remdesivir: 5 μM | 282T7766 | Tebubio |
Bortezomib: 0,1 μM | S1013 | Selleck Chemicals |
PF-00835231: 10 μM | S9731 | Selleck Chemicals |
CG-376 | SE-S0475 | Euromedex |
Nigericin | tlrl-nig-5 | Invivogen |
Hoescht | 62249 | Invitrogen |
Poly(I:C) HMW | tlrl-pic | Invivogen |
Nate | lyec-nate | Invivogen |
Lipofectamine 2000 | 11668030 | Invitrogen |
Lipofectamine LTX | 15338030 | Invitrogen |
Doxycycline | S5159 | Selleck chemicals |
Recombinant human IL-18 | (rcyec-hil18) | Invivogen |
Critical commercial assays | ||
IL-1B | 88-7261-77 | Fisher Scientific |
IL-6 | 555220 | BD |
IL-16 | DY316 | R&D |
Caspase 3 | BMS2012INST | Invitrogen |
Gasdermin E | AG-45B-0024-KI01 | Adipogen |
HMGB1 | NBP2-62766 | Novusbio |
Deposited data | ||
Original blots and microscopy images | https://doi.org/10.17632/nwhd3w9w5x.1 | Mendeley dataset |
Experimental models: Cell lines | ||
THP1 KO NLRP3 | Thp-konlrp3z | Invivogen |
THP1 | Thp-null | Invivogen |
A549 | A549d-nfis | Invivogen |
A549-Dual™ ACE2 & TMPRSS2 | a549d-cov2r | Invivogen |
A549-Dual™ KO-MAVS Cells | a549d-komavs | Invivogen |
A549 ACE2 & TMPRSS2 Cells | a549-hace2tpsa | Invivogen |
IL-18 Reporter HEK 293 Cells | (hkb-hmil18) | Invivogen |
Lonza, B-ALI kit 00193514 | 00193514 | Lonza |
Corning HTS Transwell-24 well permeable supports | CLS3379 | Corning |
Recombinant DNA | ||
LentiCas9-Blast | addgen ref 52962 | (Sanjana et al., 2014) |
p8.91 | Didier Trono lab | Didier Trono lab |
pMD.2G | addgene ref 12259 | Didier Trono lab |
LentiGuide-Puro | addgen ref 52963 | (Sanjana et al., 2014) |
Vector pLVX-EF1α-IRES-Puro Containing the SARS-CoV-2, USA-WA1/2020 3C-Like Protease Gene, C145A Mutant | BEI NR-52953 | BEI |
pLEX307-SARS-CoV-2-3CL (NSP5) | addgene #160278 | (Resnick et al., 2021) |
pSC2+ NLRP1 constructs | (Robinson et al., 2020) | |
pLV-72-Cas9-GFP | N/A | Invivogen |
pLVB-Tet ON | N/A | Invivogen |
pLVB-TetR | N/A | Invivogen |
pBRGEN | N/A | Invivogen |
pMSCV-puro | Addgene plasmid # 68469 | (Akama-Garren et al., 2016) |
pMSCV-GsdmB | GeneScript | N/A |
pMSCV-GsdmE | GeneScript | N/A |
pMSCV-GsdmD | GeneScript | N/A |
pCW57-RFP- P2A-MCS | Addgene #89182 | (Barger et al., 2021) |
LENTI V2 plasmid | Addgene 52961 | N/A |
Oligonucleotides | ||
sgRNA targetting Gasdermin E (Exon 2) | CAGTTTTTATCCCTCACCCT | Sigma-Aldrich |
sgRNA targetting Gasdermin E (Exon 2) | TAAGTTACAGCTTCTAAGTC | Sigma-Aldrich |
sgRNA targetting Gasdermin E (Exon 3) | GTCGGACTTTGTGAAATACG | Sigma-Aldrich |
sgRNA targetting Casp1 (Exon 2) | TTGTGAAGAAGACAGTTACC | Sigma-Aldrich |
sgRNA targetting Casp1 (Exon 4) | AAGGATATGGAAACAAAAGT | Sigma-Aldrich |
sgRNA targetting Gasdermin D (Exon 5) | TTAGGAAGCCCTCAAGCTCA | Sigma-Aldrich |
sgRNA targetting Gasdermin D (Exon 6) | GAATGTGTACTCGCTGAGTG | Sigma-Aldrich |
sgRNA targetting Gasdermin D (Exon 5) | AGGTTGACACACTTATAACG | Sigma-Aldrich |
sgRNA targetting Caspase 3 (Exon 4) | CATACATGGAAGCGAATCAA | Sigma-Aldrich |
sgRNA targetting Caspase 3 (Exon 5) | TGTCGATGCAGCAAACCTCA | Sigma-Aldrich |
sgRNA targetting MAVS | ACCTCAGCAGATGATAGGCTCGGCC | Sigma-Aldrich |
sgRNA targetting MAVS | ACCTCGCCCATCAACTCAACCCGTGC | Sigma-Aldrich |
sgRNA targetting NLRP1 (Exon 2) | GCTCAGCCAGAGAAGACGAG | Sigma-Aldrich |
sgRNA targetting NLRP1 | GATAGCCCGAGTGACATCGG | Sigma-Aldrich |
sgRNA targetting NLRP1 | AGCCCGAGTGACATCGGTGG | Sigma-Aldrich |
sgRNA targetting GFP | GGAGCGCACCATCTTCTTCA | Sigma-Aldrich |
Fwd Q333A | GAACCTCGCATAGTCATACT GGCGGGGGCTGCTGGAATTGGGAAG |
Sigma-Aldrich |
Rev Q333A | CTTCCCAATTCCAGCAGCCCCCGCCA GTATGACTATGCGAGGTTC |
Sigma-Aldrich |
HA-GsdmD Q335A fwd2 | GGCGCTGGAGgccGGCCAGAGCCTT GGGCC |
Sigma-Aldrich |
HA-GsdmD Q335 rev2 | cgcaaccccaaccccggatccCTAGTGGGG CTCCTGGCTC |
Sigma-Aldrich |
HA-GsdmD Q193 fwd | cagatcgcctggagaattggctagcATGTACCCA TACGATGTTCCA |
Sigma-Aldrich |
HA-GsdmD Q193 rev | cgcaaccccaaccccggatcctcaCTGCAAGC ACGTGGCTC |
Sigma-Aldrich |
HA-GsdmD N-ter fwd | cagatcgcctggagaattggctagcATGTACCC ATACGATGTTCC |
Sigma-Aldrich |
HA-GsdmD N-ter rev | cgcaaccccaaccccggatcctcaATCTGTCA GGAAGTTGTGG |
Sigma-Aldrich |
GsdmD Q193 fwd1 | aggcgccggaattagatctctcgagatggactaca aagacgatgacgacaagGGTGGAGGTGGA GGTGGA |
Sigma-Aldrich |
GsdmD Q193A rev1 | GGCCCTCACCggcCAAGCACGTGGC TCCGG |
Sigma-Aldrich |
HA-GsdmD Q193A fwd2 | CACGTGCTTGgccGGTGAGGGCCAG GGCCAT |
Sigma-Aldrich |
GsdmD Q193 rev2 pMSCV | ctcccctacccggtagaattcCTAGTGGGGC TCCTGGCTC |
Sigma-Aldrich |
GsdmD Q335 fwd1 | aggcgccggaattagatctctcgagatggacta caaagacgatgacgacaagGGTGGAGG TGGAGGTGGAG |
Sigma-Aldrich |
GsdmD Q335A rev1 | GGCTCTGGCCggcCTCCAGCGCC TCCTCCAA |
Sigma-Aldrich |
HA-GsdmD Q335A fwd2 | GGCGCTGGAGgccGGCCAGAGC CTTGGGCC |
Sigma-Aldrich |
GsdmD Q335 rev2 pMSCV | ctcccctacccggtagaattcCTAGT GGGGCTCCTGGCTC |
Sigma-Aldrich |
Recombinant proteins | ||
Recombinant SARS-COV 3CL | E-718-050 | Novusbio |
Recombinant SARS-CoV-2 3CL | E-720-050 | Novusbio |
Recombinant MERS-CoV 3CL | E-719-050 | Novusbio |
Recombinant human caspase-1 protein (active) | Ab39901 | Abcam |
Nsp3, peptidase C16 of PLpro | PX-COV-P004 | proteogenix |
HRV3C Protease | SAE0045 | Sigma-Aldrich |
Software and algorithms | ||
Snapgene | GSL Biotech LLC, Chicago, U.S.A. | N/A |
Fiji (Image J) | N/A | |
Benchling Software | N/A | |
Image Lab 6.1 (Biorad) | N/A | |
Biorender.com | N/A | |
Graphpad 8.0a | N/A | |
Uniprot database | N/A |